Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Idiopathic pulmonary fibrosis+1

Not recruiting

Investigational

Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Bi 1839100

Contact Research Centre

Idiopathic pulmonary fibrosis

Not recruiting

Investigational

Study on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Bi 1819479

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Interstitial lung disease

Not recruiting

Investigational

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Investigational

Austria

Participants:65+ years
Substances:Bi 1015550

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Comparison of intravenous versus subcutaneous isatuximab with lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma patients eligible for transplant

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Sotorasib Alone and Combined with Pembrolizumab in Adult Patients with Advanced Solid Tumors Having KRAS p.

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Sotorasib

Contact Research Centre

Idiopathic pulmonary fibrosis

Not recruiting

InvestigationalNo placebo

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Bi 1015550

Contact Research Centre

Follicular lymphoma

Not recruiting

Registered drugNo placebo

Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing ABBV-383 with Standard Therapies for Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Bladder cancer

Not recruiting

Registered drugNo placebo

Study Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Bladder cancer

Not recruiting

Registered drugNo placebo

Study on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Small cell lung cancer recurrent

Not recruiting

Registered drugNo placebo

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Ammonium Chloride

Contact Research Centre

Find therapies in clinical trials near you – page 3

39 trials match your criteria

Idiopathic pulmonary fibrosis+1

Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis

Idiopathic pulmonary fibrosis

Study on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis

Plasma cell myeloma

Study on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment

Interstitial lung disease

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Plasma cell myeloma

Comparison of intravenous versus subcutaneous isatuximab with lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma patients eligible for transplant

Non-small cell lung cancer

Study of Sotorasib Alone and Combined with Pembrolizumab in Adult Patients with Advanced Solid Tumors Having KRAS p.

Idiopathic pulmonary fibrosis

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

Follicular lymphoma

Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma

Plasma cell myeloma

Study Comparing ABBV-383 with Standard Therapies for Adults with Relapsed or Refractory Multiple Myeloma

Bladder cancer

Study Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer

Bladder cancer

Study on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin

Small cell lung cancer recurrent

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.